Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

National Institute for Health and Care Excellence NICE logo

NICE persuaded to back Praluent as well as Repatha

Comes after Sanofi follows Amgen in discounting the price of its drug

- PMLiVE

Drone delivery of vaccine supplies planned in Rwanda

Gavi, UPS and Zipline hope new network will be a test-case for other countries

China flag thumb

Chinese biotech claims 90% cure rate for CAR-T therapy

Innovative Cellular Therapeutics presents ‘stellar’ immunotherapy data

UK flag

UK biopharma says Brexit would be “bad for business”

Over 90 industry leaders sign letter supporting the Remain campaign

eHealth set to benefit from EC’s ‘single digital market’

Says will help European industry, researchers and public authorities

- PMLiVE

Creative directors join The Prime Medical Group’s UK offices

Adam Moriarty and Craig Armstrong join London and Cheshire teams

FDA knocks-back Otsuka’s digital pill plans

Wants more data on its combination of Abilify and Proteus sensor and pill

- PMLiVE

Delivering a better eDetail: Strategy-led user-centred methodology in practice

Stuart Goodman and Anna Tamasi demonstrate how user-centred design helps to build better strategy and assets for pharma and healthcare.

Blue Latitude Health

Deal Watch March 2016

AstraZeneca, Roche, Sanofi and Valeant are featured in this month’s roundup of pharma deals

- PMLiVE

Pfizer signs $900m-plus deal with WAVE for metabolic R&D

Will collaborate on five programmes to explore the cause of genetically defined diseases

Sanofi reception

Sanofi hints at sweetened Medivation deal – or hostile bid

CEO Oliver Brandicourt claims “overwhelming support” for deal from shareholders

Tiziana Life Sciences appoints clinical sciences VP

Dr Robert Evans joins the UK biotechnology firm

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links